Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

NEW YORK, Nov. 26, 2020 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  Biogen Inc. (NASDAQ: BIIB) between October 22, 2019 and November 6, 2020, inclusive (the “Class Period”).

To join the class action, go to  http://zhanginvestorlaw.com/join-action-form/?slug=biogen-inc&id=2484 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email  [email protected]  for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。 http://zhanginvestorlaw.com/join-action-form/?slug=biogen-inc&id=2484.

If you wish to serve as lead plaintiff, you must move the Court before the January 12, 2021 DEADLINE.   A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. 

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: the larger dataset did not provide

Read More

Pomerantz Law Firm Announces the Filing of a Class Action against Neovasc Inc. and Certain Officers – NVCN

NEW YORK, Nov. 25, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) and certain of its officers.  The class action, filed in United States District Court for the Southern District of New York, and docketed under 20-cv-09948, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Neovasc securities between October 10, 2018 and October 27, 2020, inclusive (the “Class Period”).  Plaintiff pursues claims against the Defendants under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Neovasc securities during the Class Period, you have until January 5, 2021, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action,

Read More

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BMRN, CACC and TRQ

The MarketWatch News Department was not involved in the creation of this content.

November 24, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 24, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Investors Affected : February 28, 2020 – August 18, 2020

A class action has commenced on behalf of certain shareholders in BioMarin Pharmaceutical Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) differences between the Phase 1/2 and Phase 3 study of valoctocogene roxaparvovec, an investigational adenoassociated

Read More

Pomerantz Law Firm Announces the Filing of a Class Action against Neovasc Inc. and Certain Officers

NEW YORK, Nov. 25, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) and certain of its officers.  The class action, filed in United States District Court for the Southern District of New York, and docketed under 20-cv-09948, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Neovasc securities between October 10, 2018 and October 27, 2020, inclusive (the “Class Period”).  Plaintiff pursues claims against the Defendants under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Neovasc securities during the Class Period, you have until January 5, 2021, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action,

Read More

DEADLINE ALERT for TCMD, CACC, ACB, PGEN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

The MarketWatch News Department was not involved in the creation of this content.

BENSALEM, Pa., Nov 24, 2020 (GLOBE NEWSWIRE via COMTEX) —
BENSALEM, Pa., Nov. 24, 2020 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected]

Tactile Systems Technology, Inc. (NASDAQ: TCMD)
Class Period: May 7, 2018 – June 8, 2020
Lead Plaintiff Deadline: November 30, 2020

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the

Read More

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PT, BTU and BIIB

The MarketWatch News Department was not involved in the creation of this content.

November 23, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 23, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Pintec Technology Holdings Limited (NASDAQ:PT)

This lawsuit is on behalf of shareholders who purchased PT securities pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s October 2018 initial public offering.

A class action has commenced on behalf of certain shareholders in Pintec Technology Holdings Limited. The filed complaint alleges that defendants made materially false and/or misleading

Read More

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen, Inc. (BIIB) Investors

BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Biogen, Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) securities between October 22, 2019 and November 6, 2020, inclusive (the “Class Period”). Biogen investors have until January 12, 2021 to file a lead plaintiff motion.

Investors suffering losses on their Biogen investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected]

Biogen develops therapies for treating neurological and neurodegenerative diseases. One of its product candidates is aducanumab (BIIB037), an investigational human monoclonal antibody studied for use as a treatment for early Alzheimer’s disease.

On October 22, 2019, the Company announced that it would seek regulatory approval from the U.S. Food and Drug Administration (“FDA”) for aducanumab “based

Read More

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of HP Inc. (HPQ) Investors

LOS ANGELES, Nov. 24, 2020 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired HP Inc. (“HP” or the “Company”) (NYSE: HPQ) common stock between November 6, 2015 and June 21, 2016, inclusive (the “Class Period”). HP investors have until January 4, 2021 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On June 21, 2016, after the market closed, HP revealed that it would reduce its Supplies channel inventory by $450 million, resulting in a corresponding reduction of $450 million in Supplies revenue over the remainder of 2016. 

On this news, HP’s stock price fell $0.72, or 5.4%, to close at $12.61 per share on June 22, 2016.

The complaint filed in this

Read More

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Berry Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Berry Corporation (“Berry” or “the Company”) (NASDAQ: BRY) violations of the federal securities laws.

Investors who purchased the Company’s shares pursuant and/or traceable to the Company’s July 26, 2018 initial public offering (the “IPO”), or between July 26, 2018 and November 3, 2020 both dates inclusive (the “Class Period”), are encouraged to contact the firm before January 21, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class, in this case, has not

Read More

Norfolk City Council to hear pro-gun group’s proposal to prohibit local gun law changes

NORFOLK, Va. (WAVY) — Voters have two chances to let their views be known on a proposed ordinance that would prohibit any further changes to local gun laws.

The public hearings were scheduled after a pro-gun group — the Norfolk 2nd Amendment Preservation Coalition — was successful in gathering enough signatures to force City Council to hold them.

The public hearings are scheduled for Tuesday and Dec. 8.

As written, the ordinance states that the city would not exercise any “authority granted to it” to regulate or prohibit the purchase, possession, transfer, ownership, carrying, storage or transporting of firearms, ammunition or components, or any combination of those items.

In addition, the ordinance also calls for the city to waive its sovereign immunity as it relates to any injury sustained by a person in a designated firearm-free zone.

“I don’t want them to regulate guns outside anything they’ve already done in

Read More